Scarica l'app Stockscreener
272.11
0.99%
2.68
Pre-mercato:
271.51
-0.60
-0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Amgen Inc Borsa (AMGN) Ultime notizie
Diversify Advisory Services LLC Cuts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Boosted by Diversify Wealth Management LLC - MarketBeat
Cell and Gene Therapy Market Set to Witness Significant Growth by 2025-2032: Pfizer, Inc., Sanofi S.A., Amgen, - EIN News
Amgen: Likely To Be Rangebound (Rating Downgrade) - Seeking Alpha
Corundum Group Inc. Has $1.04 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Willner & Heller LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer - Yahoo Finance Australia
Amgen Inc. (AMGN): A Bull Case Theory - Insider Monkey
Annex Advisory Services LLC Has $4.11 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
FDA approves Amgen’s combo therapy for colorectal cancer - Yahoo Finance
Sax Wealth Advisors LLC Makes New $252,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Kelly Financial Services LLC Invests $3.78 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Here’s Why Amgen Inc. (AMGN) Is Among the Highest Yielding Dividend Stocks In the Dow - Insider Monkey
HB Wealth Management LLC Buys 1,768 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cohen Klingenstein LLC Sells 1,750 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Verity & Verity LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Trimmed by Aaron Wealth Advisors LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Lifted by Merit Financial Group LLC - MarketBeat
Why Amgen Inc. (AMGN) Is One of the Best Cheap Stocks to Buy for 2025? - Insider Monkey
Amgen picks up key colorectal cancer okay for KRAS drug - pharmaphorum
Why Is Amgen Inc. (AMGN) Among Louis Navellier’s Top Long-term Stock Picks? - Insider Monkey
Avanza Fonder AB Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Tompkins Financial Corp Buys 16,481 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Zoran Krunic, Senior Manager of Data Science at Amgen The Superposition Guy's Podcast: Workforce Development - The Quantum Insider
Boston Common Asset Management LLC Has $5.66 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Householder Group Estate & Retirement Specialist LLC Has $412,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Empirical Asset Management LLC Purchases 3,156 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ritholtz Wealth Management Decreases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's (NASDAQ:AMGN) Upcoming Dividend Will Be Larger Than Last Year's - Simply Wall St
Novo shares high-dose Wegovy results; Amgen, AstraZeneca drugs get expanded OKs - BioPharma Dive
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation - Benzinga
Amgen : Advancement in Combination Biomarker Driven Therapy for Adult Patients with Chemorefractory KRAS G12C Mutated Metastatic Colorectal Cancer (mCRC) - Marketscreener.com
FDA Approves Amgen’s LUMAKRAS + Vectibix for KRAS G12C-mutated Colorectal Cancer - Contract Pharma
FDA approves Amgen's Lumakras with Vectibix for mCRC - World Pharmaceutical Frontiers
FDA Approves Amgen's Groundbreaking LUMAKRAS Combination Therapy for Colorectal Cancer Treatment - StockTitan
Looking beyond obesity, Amgen wins colorectal cancer expansion for Lumakras - PharmaLive
FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients - GuruFocus.com
Occidental Asset Management LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,620 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Bennett Associates Wealth Management - MarketBeat
Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer - Seeking Alpha
Carnegie Investment Counsel Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
JGP Wealth Management LLC Increases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,041 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Tallon Kerry Patrick - MarketBeat
Engineered Multispecific Antibodies Innovation Research Report 2024: Patent Trends Show a Noticeable Surge in 2023 with Regeneron, Roche, and Amgen Emerging as the Top Patent Filers - GlobeNewswire Inc.
7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.
Godsey & Gibb Inc. Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
US FDA approves Amgen's colorectal cancer therapy - Reuters.com
Is Amgen Inc. (AMGN) Among the Best NASDAQ Dividend Stocks to Buy? - Insider Monkey
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
Flywheel Private Wealth LLC Acquires New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Argent Capital Management LLC - MarketBeat
Alzheimers Drugs Market Projected To Reach USD 12.26 Bn by - GlobeNewswire
Amgen Reveals Ocrelizumab Biosimilar Ambitions - News & Insights
Wolff Wiese Magana LLC Purchases 1,644 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Avity Investment Management Inc. Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Assenagon Asset Management S.A. Cuts Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Lifted by Thurston Springer Miller Herd & Titak Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Park Avenue Securities LLC - MarketBeat
Pines Wealth Management LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
SeaCrest Wealth Management LLC Lowers Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Fed. Circ. Judge Asks What's The Rush In Eylea Biosimilar Case - Law360
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - MSN
JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning - BioPharma Dive
Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Sling Brings Potential Oral Competition To Amgen’s Tepezza In TED - News & Insights
Amgen Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
0.72%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):